14 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $194M | -$11M | 85.7% | -4.0% | -48.6% | -16.0% | $6M | — | $37M |
| 2024 | $155M | $25M | 86.2% | -13.2% | -269.9% | 32.2% | $16M | — | $33M |
| 2023 | $153M | $18M | 87.6% | -9.5% | 508.9% | 30.5% | $9M | — | — |
| 2022 | $119M | -$46M | 84.3% | -36.5% | 399.6% | -177.4% | -$23M | — | — |
| 2021 | $93M | -$61M | 80.6% | -58.5% | -267.8% | -122.0% | -$33M | — | — |
| 2020 | $37M | -$59M | 76.2% | -155.0% | 2547.8% | -437.6% | — | — | — |
| 2019 | $12M | -$3M | 79.7% | -23.2% | 317.5% | -91.0% | — | — | — |
| 2018 | $42515 | -$1M | 14883.9% | -4836.3% | -138.2% | -47.4% | — | — | — |
| 2017 | — | -$1M | — | — | -136.7% | -95.4% | — | — | — |
| 2016 | — | -$1M | — | — | 311.8% | -140.2% | — | — | — |
| 2015 | — | -$61992 | — | — | -61.9% | -13.8% | — | — | — |
| 2014 | — | -$460485 | — | — | 330.1% | -262.8% | — | — | — |
| 2013 | — | -$268262 | — | — | -137.2% | -48.6% | — | — | — |
| 2012 | — | -$445649 | — | — | -330.1% | -120.5% | — | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | $47M | -$7M | 88.8% | -15.1% | -88.9% | -11.8% | -$7M | — | $25M |
| Mar '26 | $50M | -$9M | 88.2% | -17.8% | -59.0% | -12.7% | $339446 | — | $34M |
| Dec '25 | $7M | $20M | 40.2% | -87.9% | 86.2% | 28.4% | -$3M | — | $37M |
| Sep '25 | $60M | -$4M | 87.7% | -3.3% | -289.6% | -5.8% | -$944394 | — | — |
| Jun '25 | $49M | -$2M | 86.0% | -4.8% | 90.9% | -2.2% | $8M | $16M | $33M |
| Mar '25 | $51M | -$183778 | 84.0% | -2.3% | 7.9% | -0.2% | $3M | — | $32M |
| Dec '24 | $60M | -$5M | 84.2% | -6.5% | 54.4% | -6.5% | $875391 | — | $33M |
| Sep '24 | $53M | -$5M | 90.6% | -7.5% | 60.3% | -6.4% | $6M | — | — |
| Jun '24 | $51M | -$7M | 90.1% | -12.4% | 163.5% | -10.8% | $4M | — | — |
| Mar '24 | $44M | -$7M | 89.6% | -14.0% | 800.7% | -11.0% | $5M | — | — |
| Dec '23 | $45M | -$4M | 88.1% | -4.8% | -106.5% | -6.4% | $6M | — | — |
| Sep '23 | $39M | -$6M | 87.6% | -11.8% | 48.3% | -15.0% | $1M | — | — |
| Jun '23 | $36M | -$7M | 87.3% | -13.6% | 42.0% | -19.0% | $5M | — | — |
| Mar '23 | $33M | -$4M | 87.3% | -8.6% | 33.4% | -11.8% | -$3M | — | — |
| Dec '22 | $28M | -$12M | 85.5% | -36.9% | 104.7% | -46.5% | -$2M | — | — |
| Sep '22 | $31M | -$7M | 85.0% | -22.5% | 1280.9% | -21.8% | -$3M | — | — |
| Jun '22 | $30M | -$13M | 84.8% | -42.4% | -370.8% | -34.3% | -$10M | — | — |
| Mar '22 | $29M | -$13M | 81.9% | -45.1% | -100.9% | -51.8% | -$8M | — | — |
| Dec '21 | $27M | -$18M | 79.7% | -49.8% | -79.6% | -36.3% | -$6M | — | — |
| Sep '21 | $25M | -$14M | 79.6% | -50.5% | 81.7% | -87.8% | -$7M | $11M | — |
How the market has priced LFMD against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Lifemd, Inc.'s revenue has grown 39.1% per year. These are computed facts, not advice.
As of FY2025, Lifemd, Inc. reported — of total debt against $37M of cash; operating income covered interest expense -5.6×.
In FY2025, gross margin was 85.7%, operating margin -4.0%, and net margin -5.8%.
As of Sep '26, Lifemd, Inc. traded at a price-to-earnings ratio of about 7.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.